Venous Insufficiency

in Overview of Vascular Disease

Applied

Type

Addition

Confidence

90%

Created

Mar 26, 2026

Evidence

2 sources

Rationale

The original text focused solely on the pathophysiology of venous ulcers. I integrated the new guideline on non-pneumatic compression (NPC) to address the management of CVI-related lymphedema and the meta-analysis on platelet-rich plasma (PRP) to provide evidence-based treatment options for the venous ulcers mentioned in the text. Abbreviations (CVI, NPC, PRP) were expanded on first use as per instructions.

Evidence

Jacobowitz GR et al. Non-pneumatic compression and its clinical utility in management of lymphedema. A position statement endorsed by the American Venous Forum and the American Venous and Lymphatic Society. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 41271100.
Verified source
PubMedDOI
Rodrigues-Guimarães T et al. Meta-analysis of platelet-rich plasma for venous ulcers: Clinical efficacy and complications. J Plast Reconstr Aesthet Surg. 2026. PMID: 41643347.
Verified source
PubMedDOI

Content Changes

Venous reflux increases hydrostatic pressure, leading to capillary leak, leukocyte trapping, inflammation, and tissue damage. This cascade underlies chronic venous ulcers [@evar2010]. Management of chronic venous insufficiency (CVI) and associated lymphedema often involves compression therapy; non-pneumatic compression (NPC) has been recognized for its clinical utility in managing these conditions [@jacobowitz2025]. For refractory venous ulcers, platelet-rich plasma (PRP) has shown clinical efficacy in improving healing rates and outcomes [@meta-analysis2026].
Go to section in textbookDispute / Submit evidenceAll updates